Besides avoiding broad-spectrum antibiotic use, “delabeling” children as penicillin-allergic resulted in significant antibiotic cost savings for families.
Most children with a reported allergy to penicillin are not actually allergic and could tolerate penicillin therapy. This is important because patients who report penicillin allergy spend more time in the hospital and have more exposure to broader-spectrum antibiotics.
In a previous study, researchers found that 76% of children who presented to a pediatric emergency department (PED) reporting penicillin allergy were at low risk for allergy based on a symptom questionnaire. Of 100 children subsequently tested, none were found to be allergic (NEJM JW Pediatr Adolesc Med Aug 2017 and Pediatrics 2017; 140:e20170471).
In the current follow-up of those 100 nonallergic children, investigators assessed subsequent antibiotic use and safety outcomes, a…
Reviewing Author
DisclosuresGrant/Research SupportNIH Institutional Clinical and Translational Science Award; Agency for Healthcare Research and Quality National Center for Pediatric Practice Based Research Learning; Patient-Centered Outcomes Research Institute
Editorial BoardsCurrent Problems in Pediatric Adolescent Healthcare
Leadership Positions in Professional Societies College of Physicians of Philadelphia (Board of Trustees)
DisclosuresGrant/Research SupportNIH Institutional Clinical and Translational Science Award; Agency for Healthcare Research and Quality National Center for Pediatric Practice Based Research Learning; Patient-Centered Outcomes Research Institute
Editorial BoardsCurrent Problems in Pediatric Adolescent Healthcare
Leadership Positions in Professional Societies College of Physicians of Philadelphia (Board of Trustees)